Mental Health

High-dose antipsychotics place children at increased risk of unexpected death

Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according to a Vanderbilt University Medical Center study published today in JAMA Psychiatry.
Unexpected death includes deaths due to unintentional drug overdose or cardiovascular/metabolic causes.

Heckers honored by National Alliance on Mental Illness

Stephan Heckers, MD, MSc, William P. and Henry B. Test Professor of Schizophrenia Research and chair of the Department of Psychiatry and Behavioral Sciences, was recently recognized by the National Alliance on Mental Illness (NAMI) with a 2018 Exemplary Psychiatrist Award.

Fibromyalgia: More doctor visits mean fewer suicide attempts

Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.

Awards bolster investigators’ bipolar disorders research

Two Vanderbilt University researchers have been awarded Blake A. Jenkins Discovery Awards in support of basic and/or translational research into bipolar disorder and related conditions with an emphasis on early detection, intervention and utilizing brain imaging.

Shared genetics may shape treatment options for certain brain disorders

Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an international consortium led by researchers from Vanderbilt University and Virginia Commonwealth University is reporting.

Environmental Health and Safety’s Wheaton retires

If you chat with Bob Wheaton, executive director of Vanderbilt Environmental Health and Safety, for a few minutes, it quickly becomes clear he’s not from around here.

1 9 10 11 12 13